MedTrace Logo

Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients

NCT00695539 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 810

Last updated 2009-10-05

No results posted yet for this study

Summary

This is a single-arm, phase IV, open-label, prospective, non interventional study to evaluate the efficacy, tolerability and safety of rosuvastatin administered for 24 weeks in approximately 900 Greek subjects with hypercholesterolemia under normal clinical practice.

Conditions

  • Hypercholesterolaemia

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-12-31
Completion
2008-12-31

Countries

  • Greece

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00695539 on ClinicalTrials.gov